Analysis of the First- and Second-Generation Raving Dragon Novelty Bath Salts Containing Methylone and Pentedrone

In recent years, a large number of designer drugs sold as “Bath Salts” have appeared on the market. In July of 2011, Raving Dragon Novelty Bath Salts was obtained over the Internet. This product became unavailable in October of that year coinciding with the DEA issuing a temporarily schedule of mephedrone, methylone, and MDPV. Four months later in February of 2012, a new product was released from the same company under the new name Raving Dragon Voodoo Dust. The contents of both products were identified using spectroscopy methods: nuclear magnetic resonance, infrared, UV–visible, tandem mass spectrometry, and high-resolution time-of-flight mass spectrometry. It was determined that Raving Dragon Novelty Bath Salts contained methylone. The replacement product Raving Dragon Voodoo Dust contained the unscheduled drug pentedrone. The Raving Dragon brand of products illustrates the rapid change of ingredients in these products to circumvent laws restricting availability, distribution, and use.     

‘Dégage RCD!’ The rise of internal dissent in Ben Ali’s Constitutional Democratic Rally and the Tunisian uprisings

This article examines the historical evolution of Tunisia’s Constitutional Democratic Rally (RCD) from its beginnings in 1987, when President Zine el-Abidine Ben Ali took power, until his ousting in 2011 when the party was outlawed. I argue that the RCD evolved from a political force with wide popular support during a short democratic era (1987–89) into a repressive interest group in the 1990s, when the regime cracked down on political dissidents and popular freedoms whilst rewarding party members with lucrative benefits. In the 2000s the RCD adopted a quasi-mafiosi structure that profited the Ben Ali family, which increasingly monopolized economic and political power. Tunisia’s transformation into a near dynasty marginalized many RCD members and its wider networks, a central dynamic to understand Ben Ali’s ousting in 2011.     

Bureaucratic Migration Politics: German Support for Common EU Policies on Labour Migration

As a macrostructure, this article uses a bureaucratic politics framework to understand the preference formation of the German federal government on liberalising economic migration policies. This allows unpacking the process of preference formation and linking it to a number of causal factors, which, by influencing the costs and benefits distribution of the relevant actors, shape the position of the government. The article argues that the misfit between the existing national regulations for economic migration and European-level policies has to be zero – otherwise the economic and political adaptation costs for the actors involved are too high. A heated national debate on immigration is negatively related to governmental support for such measures, as the political costs of support skyrocket. Conversely, if the decision-making process happens bureaucratically, this helps to attain governmental support, as the political costs of doing so are kept minimal.     

Public Administration, Science, and Risk Assessment: A Case Study of the U.K. Bovine Spongiform Encephalopathy Crisis

The bovine spongiform encephalopathy (BSE) outbreak in the United Kingdom is regarded as one of the worst public policy crises the British government has experienced during the postwar era. In material terms, it has led to the slaughter of 3.3 million cattle and estimated economic losses of £3.7 billion. In administrative terms, the crisis brought about the dissolution of the Ministry of Agriculture, Fisheries and Food. This article examines the istitutional context in which decisions about the scientific evidence on BSE were made. The authors argue that a centralized system in which government agencies control science for government is inherently vulnerable to alliances of experts and interest groups that undermine the credible assessment of public health and safety risks. Specific societal conditions may encourage risk-opportunistic behavior among policy makers that is conducive to delays and inaction until such time as the evidence of a health risk becomes overwhelming.     

Where do NGOs fit in?

The contribution of NGOs to the health sector has changed over recent years. Their profile and sector size have increased, and their activities are often different from those previously carried out. In some quarters NGOs are viewed as the best means of developing the health sector: regarded, among other things, as being more efficient and accountable than many developing-country governments. This article explores these developments and examines in particular one aspect that has been relatively ignored: the relationship between governments and the NGO sector within the health field. It concludes by looking at practical steps that can be taken to improve such relationships.     

Genetic Testing and the Future of Disability Insurance: Ethics, Law & Policy

Predictive genetic testing poses fundamental questions for disability insurance, a crucial resource funding basic needs when disability prevents income from work. This article, from an NIH-funded project, presents the first indepth analysis of the challenging issues: Should disability insurers be permitted to consider genetics and exclude predicted disability? May disabilities with a recognized genetic basis be excluded from coverage as pre-existing conditions? How can we assure that private insurers writing individual and group policies, employers, and public insurers deal competently and appropriately with genetic testing?